University of Washington

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).

1,048 total trials 156 currently recruiting 720 completed early-phase tilt top decile by trial count

University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.

University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.

Top-decile sponsor footprint

University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,048 total, page 16 of 21

COMPLETED NA

cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose

NCT01332825
COMPLETED Phase 2

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days

NCT01547169
COMPLETED

Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)

NCT01295242
COMPLETED Phase 1

ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

NCT01215292
COMPLETED NA

Supporting Parents Program: Intervention for Families in CPS

NCT01332851
TERMINATED Phase 1

Piloting Acute Care to Primary Care Linkage of Safety Net Patients

NCT01347541
COMPLETED Phase 2

Study of Cimzia for the Treatment of Ulcerative Colitis

NCT01090154
COMPLETED NA

Homeopathic Cold Remedy for Children Study

NCT01257503
COMPLETED NA

Breast Displacement and CT Radiation Dose

NCT01261559
COMPLETED NA

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

NCT01153672
COMPLETED Phase 2

Efficacy Trial of Warrior Check-Up

NCT01128140
COMPLETED Phase 1

AMD 3100 for Treatment of Myelokathexis

NCT01058993
TERMINATED NA

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

NCT02149173
COMPLETED Phase 1

Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma

NCT01165112
COMPLETED NA

L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer

NCT01155609
COMPLETED

Back Pain Outcomes Using Longitudinal Data (BOLD)

NCT01776242
COMPLETED

Brain Regulation of Appetite in Twins

NCT02483663
COMPLETED Phase 2

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

NCT01101880
COMPLETED Phase 2

Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)

NCT00977041
COMPLETED Phase 2

Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma

NCT01110135
COMPLETED NA

Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)

NCT01161446
COMPLETED NA

Resveratrol and Midazolam Metabolism

NCT01173640
COMPLETED NA

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease

NCT01684722
COMPLETED Phase 1

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

NCT01167829
COMPLETED Phase 1

Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

NCT01104259
COMPLETED Phase 4

Effects of Simvastatin on Biomarkers

NCT01142336
TERMINATED Phase 1

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

NCT01148966
COMPLETED NA

Three Arm Trial of Immune Effects of Echinacea

NCT01129128
COMPLETED

Amputee Residual Limb Volume Fluctuation

NCT01161238
COMPLETED NA

Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial

NCT01195545
COMPLETED NA

Living Well With Stroke

NCT01133106
COMPLETED

A Client-Based Outcome System for Individuals With Lower Limb Amputation

NCT01750372
COMPLETED

Self-collected Swabs for HPV Testing in 18-24 Year Old Women

NCT01101828
COMPLETED

The Effect of a Meal on Brain Activation in Reward Pathways

NCT01631045
COMPLETED Phase 1

A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients

NCT01093521
COMPLETED NA

Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study

NCT01088867
COMPLETED Phase 2

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

NCT01023061
COMPLETED NA

Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.

NCT01059058
COMPLETED NA

Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling

NCT01529047
COMPLETED NA

Safety and Tolerability of Coenzyme Q10 in Hemodialysis Patients

NCT00908297
COMPLETED NA

MOMCare: Culturally Relevant Treatment Services for Perinatal Depression

NCT01045655
COMPLETED Phase 1

Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients

NCT01178359
COMPLETED

Mechanisms of Glycemic Improvement After Gastrointestinal Surgery

NCT01025999
COMPLETED

Chronic Pain and Brain Activity in Spinal Cord Injury

NCT01012635
COMPLETED NA

Depression Attention for Women Now (The DAWN Study)

NCT01096316
COMPLETED NA

Transversus Abdominis Plane (TAP) Block for Cesarean Section

NCT01015807
COMPLETED NA

Homeopathic Ear Drops for Otitis Media Study

NCT01003210
COMPLETED Phase 1

Mindfulness Based Relapse Prevention: Efficacy and Mechanisms

NCT01159535
COMPLETED

Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)

NCT01167842
COMPLETED NA

Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI

NCT00947232
← Previous Page 16 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 127
Phase 2 193
Phase 3 39
Phase 4 65

Therapeutic Areas

Depression 13
Chronic Pain 9
Dementia 8
Multiple Sclerosis 8
Post Traumatic Stress Disorder 7
Stage IV Breast Cancer 6
Pain 6
Anatomic Stage IV Breast Cancer AJCC v8 6
Anatomic Stage III Breast Cancer AJCC v8 6
Spinal Cord Injuries 6

What is open in the University of Washington pipeline

156 recruiting of 1,048 indexed (15% open); 720 completed (69%).

Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).

Top condition: Depression (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Washington: open-pipeline peers nationwide

Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of WashingtonUniversity of Wisconsin, MadisonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillDompé Farmaceutici S.p.AVanderbilt-Ingram Cancer CenterArizona State UniversityGeorgetown University
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,048 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Washington page

1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.

  • 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.